Infectious Disease Diagnostics Market Size, Share, and Trends 2024 to 2034

The global infectious disease diagnostics market size is calculated at USD 35.39 billion in 2025 and is forecasted to reach around USD 66.73 billion by 2034, accelerating at a CAGR of 7.3% from 2025 to 2034. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : May 2025
  • Report Code : 3100
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Infectious Disease Diagnostics Market 

5.1. COVID-19 Landscape: Infectious Disease Diagnostics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Infectious Disease Diagnostics Market, By Product

8.1. Infectious Disease Diagnostics Market, by Product

8.1.1 Assays & Reagents

8.1.1.1. Market Revenue and Forecast

8.1.2. Instruments

8.1.2.1. Market Revenue and Forecast

8.1.3. Software

8.1.3.1. Market Revenue and Forecast

Chapter 9. Global Infectious Disease Diagnostics Market, By Disease Type

9.1. Infectious Disease Diagnostics Market, by Disease Type

9.1.1. Hepatitis

9.1.1.1. Market Revenue and Forecast

9.1.2. Human Immunodeficiency Virus

9.1.2.1. Market Revenue and Forecast

9.1.3. Influenza

9.1.3.1. Market Revenue and Forecast

9.1.4. Others

9.1.4.1. Market Revenue and Forecast

Chapter 10. Global Infectious Disease Diagnostics Market, By Technology 

10.1. Infectious Disease Diagnostics Market, by Technology

10.1.1. Immunodiagnostics

10.1.1.1. Market Revenue and Forecast

10.1.2. Clinical Microbiology

10.1.2.1. Market Revenue and Forecast

10.1.3. Polymerase Chain Reaction

10.1.3.1. Market Revenue and Forecast

10.1.4. Next-generation Sequencing

10.1.4.1. Market Revenue and Forecast

10.1.5. Others

10.1.5.1. Market Revenue and Forecast

Chapter 11. Global Infectious Disease Diagnostics Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product

11.1.2. Market Revenue and Forecast, by Disease Type

11.1.3. Market Revenue and Forecast, by Technology

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product

11.1.4.2. Market Revenue and Forecast, by Disease Type

11.1.4.3. Market Revenue and Forecast, by Technology

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product

11.1.5.2. Market Revenue and Forecast, by Disease Type

11.1.5.3. Market Revenue and Forecast, by Technology

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product

11.2.2. Market Revenue and Forecast, by Disease Type

11.2.3. Market Revenue and Forecast, by Technology

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product

11.2.4.2. Market Revenue and Forecast, by Disease Type

11.2.4.3. Market Revenue and Forecast, by Technology

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product

11.2.5.2. Market Revenue and Forecast, by Disease Type

11.2.5.3. Market Revenue and Forecast, by Technology

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product

11.2.6.2. Market Revenue and Forecast, by Disease Type

11.2.6.3. Market Revenue and Forecast, by Technology

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product

11.2.7.2. Market Revenue and Forecast, by Disease Type

11.2.7.3. Market Revenue and Forecast, by Technology

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product

11.3.2. Market Revenue and Forecast, by Disease Type

11.3.3. Market Revenue and Forecast, by Technology

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product

11.3.4.2. Market Revenue and Forecast, by Disease Type

11.3.4.3. Market Revenue and Forecast, by Technology

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product

11.3.5.2. Market Revenue and Forecast, by Disease Type

11.3.5.3. Market Revenue and Forecast, by Technology

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product

11.3.6.2. Market Revenue and Forecast, by Disease Type

11.3.6.3. Market Revenue and Forecast, by Technology

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product

11.3.7.2. Market Revenue and Forecast, by Disease Type

11.3.7.3. Market Revenue and Forecast, by Technology

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product

11.4.2. Market Revenue and Forecast, by Disease Type

11.4.3. Market Revenue and Forecast, by Technology

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product

11.4.4.2. Market Revenue and Forecast, by Disease Type

11.4.4.3. Market Revenue and Forecast, by Technology

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product

11.4.5.2. Market Revenue and Forecast, by Disease Type

11.4.5.3. Market Revenue and Forecast, by Technology

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product

11.4.6.2. Market Revenue and Forecast, by Disease Type

11.4.6.3. Market Revenue and Forecast, by Technology

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product

11.4.7.2. Market Revenue and Forecast, by Disease Type

11.4.7.3. Market Revenue and Forecast, by Technology

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product

11.5.2. Market Revenue and Forecast, by Disease Type

11.5.3. Market Revenue and Forecast, by Technology

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product

11.5.4.2. Market Revenue and Forecast, by Disease Type

11.5.4.3. Market Revenue and Forecast, by Technology

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product

11.5.5.2. Market Revenue and Forecast, by Disease Type

11.5.5.3. Market Revenue and Forecast, by Technology

Chapter 12. Company Profiles

12.1. Abbott Laboratories

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Becton Dickinson and Company

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. bioMerieus SA

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Bio-Rad Laboratories

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Danaher Corporation

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. F Hoffman-La Roche

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Hologic Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Luminex Corporation

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Qiagen Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Thermo Fisher Scientific Inc.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global infectious disease diagnostics market size surpassed USD 30.74 billion in 2023 and it is expected to increase USD 66.73 billion by 2034 .

The global infectious disease diagnostics market will register growth rate of 7.3% between 2024 and 2034.

The major players operating in the infectious disease diagnostics market are Abbott Laboratories, Becton Dickinson and Company, bioMerieus SA, Bio-Rad Laboratories, Danaher Corporation, F Hoffman-La Roche, Hologic Inc., Luminex Corporation, Qiagen Inc., Thermo Fisher Scientific Inc., and Others.

The driving factors of the infectious disease diagnostics market are the increasing prevalence of infectious diseases, rising demand for the rapid diagnostic tests, increasing focus on early detection and prevention, and emergence or re-emergence of infectious diseases.

North America region will lead the global infectious disease diagnostics market during the forecast period 2025 to 2034

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client